Journal Reviews

New therapy for overactive bladder

1 July 2014 | | Functional Urology | Mirabegron, overactive bladder, β3-adrenoceptor agonist

Overactive bladder (OAB) is a complex symptom that can adversely affect quality of life. So far pharmacotherapy has focused on anti-cholinergic drugs. Recently, beta-adrenoreceptors have been identified as having an effect on the detrusor muscle and urothelium. Beta-3 is the...